Results 11 to 20 of about 95,754 (365)
Obeticholic Acid for Primary Biliary Cholangitis
Biomedicines, 2022 Primary biliary cholangitis (PBC) is a rare autoimmune cholestatic liver disease that may progress to fibrosis and/or cirrhosis. Treatment options are currently limited.
Annarosa Floreani +2 more
doaj +2 more sources
Awareness of Primary Biliary Cholangitis Among Turkish Physicians: A Cross-Sectional, Multicenter, Web-Based Survey [PDF]
J Clin MedHasan Eruzun, Henning Gronbaek
openalex +2 more sources
Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study [PDF]
Intestinal Research, 2023 Background/Aims We conducted a nationwide population-based study to investigate incidence rates of colorectal and biliary cancers according to accompanying primary sclerosing cholangitis in Korean ulcerative colitis patients.
Eun Hye Oh +5 more
doaj +1 more source
Frontiers in Immunology, 2022 Fibrates, which are agonists of peroxisome proliferator-activated receptor alpha, have received increasing attention in the treatment of primary biliary cholangitis.
Chang Wang +12 more
doaj +1 more source
La Revue du praticien, 2022 PRIMARY BILIARY CHOLANGITIS Primary biliary cholangitis (formally primary biliary cirrhosis, PBC) is the most common chronic cholestatic liver disease in humans. It is a presumed autoimmune liver disease, characterized by inflammation and progressive destruction of small bile ducts.
Pierre-Antoine, Soret +2 more
+6 more sources
Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports
Journal of Medical Case Reports, 2023 Background Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis is an extremely rare condition that has been reported in only few published cases so far in the literature.
Haythem Yacoub +8 more
doaj +1 more source
Mast Cells in Immune-Mediated Cholangitis and Cholangiocarcinoma
Cells, 2022 Cholestasis, which is impaired bile flow from the liver into the intestine, can be caused by cholangitis and/or bile duct obstruction. Cholangitis can arise from bacterial infections and cholelithiasis, however, immune-mediated cholangitis in primary ...
Marisol I. González +4 more
doaj +1 more source
Primary biliary cholangitis: pathogenic mechanisms
Current Opinion in Gastroenterology, 2021 Purpose of review Primary biliary cholangitis (PBC) is characterized by autoimmune damage of intrahepatic bile ducts associated with a loss of tolerance to mitochondrial antigens. PBC etiopathogenesis is intriguing because of different perplexing features, namely: a) although mitochondria are present in all cell types and ...
Prieto, Jesús +2 more
openaire +5 more sources
Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases [PDF]
, 2020 In the past ten years, our understanding of the importance of bile acids has expanded from fat absorption and glucose/lipid/energy homeostasis into potential therapeutic targets for amelioration of chronic cholestatic liver diseases.
Alpini, Gianfranco +4 more
core +1 more source
Primary biliary cholangitis: Epidemiology, prognosis, and treatment
Hepatology Communications, 2023 Primary biliary cholangitis (PBC) is a chronic cholestatic autoimmune liver disease characterized by a destructive, small duct, and lymphocytic cholangitis, and marked by the presence of antimitochondrial antibodies.
Juan Trivella, Binu V. John, C. Levy
semanticscholar +1 more source